1.Braun J, Sieper J. Ankylosing spondylitis. Lancet (London, England). 2007;369(9570):1379–90.
2.Boonen A, van der Linden SM. The burden of ankylosing spondylitis. The Journal of rheumatology Supplement. 2006;78:4–11.
3.Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770–6.
4.Masi AT, Wilkins WR. Does male:female sex ratio in ankylosing spondylitis change with age? The Journal of rheumatology. 1996;23(5):947–8.
5.Will R, Edmunds L, Elswood J, Calin A. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. The Journal of rheumatology. 1990;17(12):1649–52.
6.Lee W, Reveille JD, Davis JC, Jr., Learch TJ, Ward MM, Weisman MH. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007;66(5):633–8.
7.Feldtkeller E. [Age at disease onset and delayed diagnosis of spondyloarthropathies]. Z Rheumatol. 1999;58(1):21–30.
8.Bagcivan G, Cinar FI, Cinar M, Oflaz F, Uzun S, Pay S. Living with pain in ankylosing spondylitis: a qualitative study. Contemporary nurse. 2015;51(2–3):135–47.
9.Bostan EE, Borman P, Bodur H, Barca N. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int. 2003;23(3):121–6.
10.Barlow JH, Wright CC, Williams B, Keat A. Work disability among people with ankylosing spondylitis. Arthritis Rheum. 2001;45(5):424–9.
11.Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, et al. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. 2016;75(1):203–9.
12.Avina-Zubieta JA, Chan J, De Vera M, Sayre EC, Choi H, Esdaile J. Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study. Ann Rheum Dis. 2019;78(4):480–5.
13.Hopkins C, Moulton C. The prevalence of depression and its correlates in ankylosing spondylitis: A systematic review and meta-analysis. European Psychiatry. 2016;33:S166.
14.Zhao S, Thong D, Miller N, Duffield SJ, Hughes DM, Chadwick L, et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20(1):140.
15.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097.
16.Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010;25(9):603–5.
17.Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC public health. 2013;13:154.
18.Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011.
19.Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Archives of General Psychiatry. 2008;65(5):501–7.
20.Shen CC, Hu LY, Yang AC, Kuo BI, Chiang YY, Tsai SJ. Risk of Psychiatric Disorders following Ankylosing Spondylitis: A Nationwide Population-based Retrospective Cohort Study. Journal of Rheumatology. 2016;43(3):625–31.
21.Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. Journal of the European Academy of Dermatology & Venereology. 2017;31(7):1168–75.
22.Meesters JJ, Bremander A, Bergman S, Petersson IF, Turkiewicz A, Englund M. The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Research & Therapy. 2014;16(5):418.
23.Zou Q, Jiang Y, Mu F, Shi Y, Fang Y. Correlation of Axial Spondyloarthritis with Anxiety and Depression. Medical Science Monitor. 2016;22:3202–8.
24.Kilic G, Kilic E, Ozgocmen S. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis. Medicine. 2014;93(29):e337.
25.Jiang Y, Yang M, Lv Q, Qi J, Lin Z, Liao Z, et al. Prevalence of psychological disorders, sleep disturbance and stressful life events and their relationships with disease parameters in Chinese patients with ankylosing spondylitis. Clinical Rheumatology. 2018;37(2):407–14.
26.Dincer U, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clinical Rheumatology. 2008;27(4):457–62.
27.Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R. Comparison of serum IL–1 beta, sIL–2R, IL–6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol. 2007;26(2):211–5.
28.Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biological psychiatry. 2010;67(5):446–57.
29.Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, et al. Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study. Brain, behavior, and immunity. 2017;62:212–8.
30.Albert PR. Why is depression more prevalent in women? Journal of psychiatry & neuroscience: JPN. 2015;40(4):219–21.
31.McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. Journal of psychiatric research. 2011;45(8):1027–35.